{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:48:26Z","timestamp":1768837706990,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,18]]},"DOI":"10.7759\/cureus.101801","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:08:26Z","timestamp":1768781306000},"source":"Crossref","is-referenced-by-count":0,"title":["E-Cadherin Immunohistochemical Expression in Gastrointestinal Adenocarcinomas and Its Association With Histological and Prognostic Parameters"],"prefix":"10.7759","author":[{"given":"Sarumathi","family":"Varadan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma","family":"Balasundararajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhivya","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balaji S","family":"Mahendran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.81883","article-title":"Epidemiological review of gastric cancer in India","volume":"32","author":"Dikshit RP","year":"2011","unstructured":"Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol. 2011, 32:3-11. 10.4103\/0971-5851.81883","journal-title":"Indian J Med Paediatr Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-024-01726-8","article-title":"Epidemiology of colorectal cancer: A review with special emphasis on India","volume":"44","author":"Shivshankar S","year":"2025","unstructured":"Shivshankar S, Patil PS, Deodhar K, Budukh AM. Epidemiology of colorectal cancer: A review with special emphasis on India. Indian J Gastroenterol. 2025, 44:142-53. 10.1007\/s12664-024-01726-8","journal-title":"Indian J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy F","year":"2008","unstructured":"van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008, 65:3756-88. 10.1007\/s00018-008-8281-1","journal-title":"Cell Mol Life Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2010.076026","article-title":"E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes","volume":"63","author":"Almeida PR","year":"2010","unstructured":"Almeida PR, Ferreira VA, Santos CC, et al.. E-cadherin immunoexpression patterns in the characterisation of gastric carcinoma histotypes. J Clin Pathol. 2010, 63:635-9. 10.1136\/jcp.2010.076026","journal-title":"J Clin Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10690","article-title":"Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region","volume":"102","author":"Kanazawa T","year":"2002","unstructured":"Kanazawa T, Watanabe T, Kazama S, et al.. Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int J Cancer. 2002, 102:225-9. 10.1002\/ijc.10690","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(97)70218-x","article-title":"Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival","volume":"112(1)","author":"Jawhari A","year":"1997","unstructured":"Jawhari A, Jordan S, Poole S, et al.. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology. 1997, 112(1):46-54. 10.1016\/s0016-5085(97)70218-x","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18231\/2394-6792.2019.0016","article-title":"Evaluation of e-cadherin expression in gastric cancer as a prognostic marker","volume":"6(1)","author":"Sridevi C","year":"2019","unstructured":"Sridevi C, Pavitra K, Jijiyabai. Evaluation of e-cadherin expression in gastric cancer as a prognostic marker. Indian J Pathol Oncol. 2019, 6(1):91-7. 10.18231\/2394-6792.2019.0016","journal-title":"Indian J Pathol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-022-00593-3","article-title":"Effect of e-cadherin on prognosis of colorectal cancer: a meta-analysis update","volume":"26","author":"Chang K","year":"2022","unstructured":"Chang K, Jiang L, Sun Y, Li H. Effect of e-cadherin on prognosis of colorectal cancer: a meta-analysis update. Mol Diagn Ther. 2022, 26:397-409. 10.1007\/s40291-022-00593-3","journal-title":"Mol Diagn Ther"},{"key":"ref9","article-title":"Evaluation of E-cadherin expression in gastric cancer and its correlation with clinicopathologic parameters","volume":"11","author":"Torabizadeh Z","year":"2017","unstructured":"Torabizadeh Z, Nosrati A, Sajadi Saravi SN, et al.. Evaluation of E-cadherin expression in gastric cancer and its correlation with clinicopathologic parameters. Int J Hematol Oncol Stem Cell Res. 2017, 11:158-64.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.689139","article-title":"Overview on the role of E-cadherin in gastric cancer: dysregulation and clinical implications","volume":"8","author":"Zhao H","year":"2021","unstructured":"Zhao H, Hu H, Chen B, et al.. Overview on the role of E-cadherin in gastric cancer: dysregulation and clinical implications. Front Mol Biosci. 2021, 8:689139. 10.3389\/fmolb.2021.689139","journal-title":"Front Mol Biosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070858","article-title":"Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis","volume":"8","author":"He X","year":"2013","unstructured":"He X, Chen Z, Jia M, Zhao X. Downregulated E-cadherin expression indicates worse prognosis in Asian patients with colorectal cancer: evidence from meta-analysis. PLoS One. 2013, 8:e70858. 10.1371\/journal.pone.0070858","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i2.199","article-title":"E-cadherin in gastric cancer","volume":"12","author":"Chan AO","year":"2006","unstructured":"Chan AO. E-cadherin in gastric cancer. World J Gastroenterol. 2006, 12:199-203. 10.3748\/wjg.v12.i2.199","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21276\/ijcmr.2020.7.1.7","article-title":"E-cadherin Immunohistochemical expression in gastric carcinoma","volume":"7(1)","author":"Sadanandan A","year":"2020","unstructured":"Sadanandan A, Anuraj CN. E-cadherin Immunohistochemical expression in gastric carcinoma. Int J Contemp Med Res. 2020, 7(1):10.21276\/ijcmr.2020.7.1.7","journal-title":"Int J Contemp Med Res"},{"key":"ref14","article-title":"The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients\u2019 survival","volume":"49(4)","author":"Laz\u0103r D","year":"2008","unstructured":"Laz\u0103r D, T\u0103ban S, Ardeleanu C, et al.. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients\u2019 survival. Romanian J Morphol Embryol. 2008, 49(4):459-67.","journal-title":"Romanian J Morphol Embryol"},{"key":"ref15","article-title":"E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration","volume":"53","author":"Mayer B","year":"1993","unstructured":"Mayer B, Johnson JP, Leitl F, et al.. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 1993, 53:1690-5.","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/637308","article-title":"E-cadherin and gastric cancer: cause, consequence, and applications","volume":"2014","author":"Liu X","year":"2014","unstructured":"Liu X, Chu KM. E-cadherin and gastric cancer: cause, consequence, and applications. Biomed Res Int. 2014, 2014:637308. 10.1155\/2014\/637308","journal-title":"Biomed Res Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204234","article-title":"E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma","volume":"20","author":"Machado JC","year":"2001","unstructured":"Machado JC, Oliveira C, Carvalho R, et al.. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001, 20:1525-8. 10.1038\/sj.onc.1204234","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2023\/60578.17542","article-title":"E-cadherin immunoexpression patterns in gastric carcinoma histological subtypes: a hospital-based descriptive study","volume":"17(2)","author":"Divyagna T","year":"2023","unstructured":"Divyagna T, Jyothi C, Yeslavath K, et al.. E-cadherin immunoexpression patterns in gastric carcinoma histological subtypes: a hospital-based descriptive study. J Clin Diagn Res. 2023, 17(2):31 - 35. 10.7860\/JCDR\/2023\/60578.17542","journal-title":"J Clin Diagn Res"},{"key":"ref19","article-title":"E-cadherin expression as a differentiation marker in gastric cancer","volume":"45","author":"Karayiannakis AJ","year":"1998","unstructured":"Karayiannakis AJ, Syrigos KN, Chatzigianni E, et al.. E-cadherin expression as a differentiation marker in gastric cancer. Hepatogastroenterology. 1998, 45:2437-42.","journal-title":"Hepatogastroenterology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6063","article-title":"E-cadherin: a potential biomarker of colorectal cancer prognosis","volume":"13","author":"Christou N","year":"2017","unstructured":"Christou N, Perraud A, Blondy S, et al.. E-cadherin: a potential biomarker of colorectal cancer prognosis. Oncol Lett. 2017, 13:4571-6. 10.3892\/ol.2017.6063","journal-title":"Oncol Lett"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.199","article-title":"Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget","volume":"1","author":"Zlobec I","year":"2010","unstructured":"Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget. Oncotarget. 2010, 1:651-61. 10.18632\/oncotarget.199","journal-title":"Oncotarget"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35686","article-title":"Association between the immunohistochemistry expression of e-cadherin, beta-catenin, and CD44 in colorectal adenocarcinoma","volume":"15","author":"Tunuguntla A","year":"2023","unstructured":"Tunuguntla A, Suresh TN, Pn S. Association between the immunohistochemistry expression of e-cadherin, beta-catenin, and CD44 in colorectal adenocarcinoma. Cureus. 2023, 15:e35686. 10.7759\/cureus.35686","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27947","article-title":"The prognostic value of e-cadherin in gastric cancer: a meta-analysis","volume":"132","author":"Xing X","year":"2013","unstructured":"Xing X, Tang YB, Yuan G, et al.. The prognostic value of e-cadherin in gastric cancer: a meta-analysis. Int J Cancer. 2013, 132:2589-96. 10.1002\/ijc.27947","journal-title":"Int J Cancer"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.4612","article-title":"Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer","volume":"31","author":"Corso G","year":"2013","unstructured":"Corso G, Carvalho J, Marrelli D, et al.. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013, 31:868-75. 10.1200\/JCO.2012.44.4612","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/PAT.0b013e3283425b7f","article-title":"Loss of E-cadherin independently predicts the lymph node status in colorectal cancer","volume":"43","author":"Karamitopoulou E","year":"2011","unstructured":"Karamitopoulou E, Zlobec I, Patsouris E, et al.. Loss of E-cadherin independently predicts the lymph node status in colorectal cancer. Pathology. 2011, 43:133-7. 10.1097\/PAT.0b013e3283425b7f","journal-title":"Pathology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-03-0320","article-title":"Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer","volume":"10","author":"Graziano F","year":"2004","unstructured":"Graziano F, Arduini F, Ruzzo A, et al.. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res. 2004, 10:2784-9. 10.1158\/1078-0432.ccr-03-0320","journal-title":"Clin Cancer Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/445767-e-cadherin-immunohistochemical-expression-in-gastrointestinal-adenocarcinomas-and-its-association-with-histological-and-prognostic-parameters","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:08:27Z","timestamp":1768781307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/445767-e-cadherin-immunohistochemical-expression-in-gastrointestinal-adenocarcinomas-and-its-association-with-histological-and-prognostic-parameters"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,18]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.101801","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,18]]}}}